Mr. David Posner reports

NUTRITIONAL HIGH PROVIDES SUPPLEMENTAL AND MODIFIED DISCLOSURE IN AMENDED MANAGEMENT DISCUSSION AND ANALYSIS

Nutritional High International Inc. has filed a revised and restated management's discussion and analysis as at, and for, the three- and nine-month periods ended April 30, 2018.

The revised MD&A supersedes the previous MD&A for the same period.

The Ontario Securities Commission (the OSC), in connection with a staff review of the company's filings, requested the revisions, described herein, to the original MD&A.

The revised MD&A provides additional disclosures related to the company's operations in the U.S. cannabis industry and provides further guidance on the regulatory regimes of each of the company's respective states of operation. These additional disclosures were included to conform to the guidance provided in CSA staff notice 51-352 (revised) (Issuers with U.S. Marijuana-Related Activities).

The revised MD&A includes enhanced disclosure regarding each of the company's material assets and investments in the United States, including describing whether each asset or investment constitutes direct, indirect or ancillary involvement in the U.S. marijuana industry (as such concepts are defined in the staff notice). The revised MD&A also includes disclosures regarding the regulatory framework in each U.S. jurisdiction in which the company operates, as well as disclosures regarding its compliance with applicable laws and regulatory requirements in such jurisdictions. The revised MD&A includes a description of the company's systems for monitoring compliance with applicable laws and the regulatory requirements in each applicable U.S. jurisdiction. The company, in this disclosure, has expanded the risk factor disclosure relating to the company's involvement in the U.S. cannabis industry.

The revised MD&A also includes updates and clarifications regarding the company's financial statements for the nine months ended April 30, 2018.

Other than as expressly set forth herein, the revised MD&A does not reflect any events that occurred after the date of the filing of the original MD&A.

The revised MD&A was filed simultaneously with this press release on SEDAR.

About Nutritional High International Inc.

Nutritional High is focused on developing, manufacturing and distributing products under recognized brands in the cannabis products industry, with a specific focus on edibles and oil extracts, for medical and adult recreational use. The company works exclusively through licensed facilities in jurisdictions where such activity is permitted and regulated by state law.

Nutritional High has brought its flagship FLI edibles and extracts product line from production to market in California through its wholly owned distributor Calyx Brands Inc., and in Colorado, where its products are manufactured by a licensed producer. The company also owns a 50-per-cent interest in The Clinic Effingham (an Illinois dispensary) and is entering the Nevada, Washington State, Oregon and Canadian markets in the near future.

We seek Safe Harbor.